The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Joan H. Schiller

Comprehensive Cancer Center

University of Wisconsin Hospital and Clinics





Name/email consistency: high



  • Comprehensive Cancer Center, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA. 2004 - 2005
  • University of Wisconsin Comprehensive Cancer Center, Madison 53792, USA. 1996 - 2004
  • Department of Human Oncology, University of Wisconsin, Madison, USA. 1996 - 2003
  • William S. Middleton Veterans Administration Hospital and University of Wisconsin Department of Medicine, Madison 53705, USA. 1999 - 2001


  1. Study design issues and early stage non-small cell lung cancer. Schiller, J.H. Clin. Cancer Res. (2005) [Pubmed]
  2. Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe. Schiller, J., Tilden, D., Aristides, M., Lees, M., Kielhorn, A., Maniadakis, N., Bhalla, S. Lung. Cancer (2004) [Pubmed]
  3. Epidermal growth factor receptor as a therapeutic target in lung cancer. Schiller, J.H. Semin. Respir. Crit. Care. Med (2004) [Pubmed]
  4. Adjuvant systemic therapies in early-stage non-small-cell lung cancer. Schiller, J.H. Clin. Lung. Cancer (2003) [Pubmed]
  5. Small cell lung cancer: defining a role for emerging platinum drugs. Schiller, J.H. Oncology (2002) [Pubmed]
  6. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy. Schiller, J.H., Adak, S., Feins, R.H., Keller, S.M., Fry, W.A., Livingston, R.B., Hammond, M.E., Wolf, B., Sabatini, L., Jett, J., Kohman, L., Johnson, D.H. J. Clin. Oncol. (2001) [Pubmed]
  7. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. Schiller, J.H., Adak, S., Cella, D., DeVore, R.F., Johnson, D.H. J. Clin. Oncol. (2001) [Pubmed]
  8. Novel therapies in lung cancer management. An update on the role of topotecan. Schiller, J.H. Oncology (2001) [Pubmed]
  9. Current standards of care in small-cell and non-small-cell lung cancer. Schiller, J.H. Oncology (2001) [Pubmed]
  10. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization. Schiller, J.H., Bittner, G. Clin. Cancer Res. (1999) [Pubmed]
  11. Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival. Schiller, J.H., Storer, B., Berlin, J., Wittenkeller, J., Larson, M., Pharo, L., Larson, M., Berry, W. J. Clin. Oncol. (1996) [Pubmed]
  12. Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial. Schiller, J.H., Kim, K., Hutson, P., DeVore, R., Glick, J., Stewart, J., Johnson, D. J. Clin. Oncol. (1996) [Pubmed]
WikiGenes - Universities